Evidence map›Paper›PMID 36402905›Full record

ArticleScientific reports2022

Quantum DFT methods to explore the interaction of 1-Adamantylamine with pristine, and P, As, Al, and Ga doped BN nanotubes.

Ebrahim Nemati-Kande, Amir Pourasadi, Fatemeh Aghababaei, Samaneh Baranipour, Ata Mehdizadeh, Jaber Jahanbin Sardroodi

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ebrahim Nemati-KandeDepartment of Physical Chemistry, Faculty of Chemistry, Urmia University, Urmia, Iran. nemati.ebrahim@gmail.com.
Amir PourasadiDepartment of Physical Chemistry, Faculty of Chemistry, Urmia University, Urmia, Iran.
Fatemeh AghababaeiDepartment of Physical Chemistry, Faculty of Chemistry, Urmia University, Urmia, Iran.
Samaneh BaranipourDepartment of Chemistry, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, 35th km of Tabriz-Maragheh Road, Tabriz, Iran.
Ata MehdizadehDepartment of Chemistry, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, 35th km of Tabriz-Maragheh Road, Tabriz, Iran.
Jaber Jahanbin SardroodiDepartment of Chemistry, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, 35th km of Tabriz-Maragheh Road, Tabriz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanostructures, nowadays, found growing applications in different scientific and industrial areas. Nano-coins, nanosheets, and nanotubes are used in medical applications as sensors or drug delivery substances. The aim of this study is to explore the adsorption of 1-Adamantylamine drug on the pristine armchair boron nitride nanotubes (BNNTs) with BNNT(5,5), BNNT(6,6), and BNNT(7,7) chirality along with the P, As, Al and Ga-doped BNNTs, using the quantum mechanical density functional methods. Considering the fact that dispersion effects are important in the case of weak Van der Waals interactions, computations have been done using B3LYP hybrid functional with the implementation of the D3(BJ) empirical dispersion correction methods. Quantum theory of atoms in molecules, natural bonding orbitals, and Kohn-Sham orbitals were used to investigate the nature and type of the adsorption process. The results showed that, while the adsorption of 1-Adamantylamine on the outer surface of pristine BNNT is physical in nature, doping can improve the ability of detracted BN to adsorb the drug through chemical bonds. Also, it was found that, by increasing the radius of the BNNT the adsorption energy was decreased. In conclusion, results of the present work suggest that, Ga doped nanotube, due the chemisorption, is not an ideal nanotube in drug delivery of 1-Adamantylamine drug, whereas, the other studied cases physiosorbed the drug, and may not have serious problem in release of the 1-Adamantylamine drug.

Indexed as

NanotubesAmantadineBoron CompoundsPharmaceutical PreparationsAmantadineBoron Compoundsboron nitridePharmaceutical Preparations

Identifiers

PMID36402905
PMCPMC9675779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.